InvestorsHub Logo

Toofast520

03/13/19 10:22 AM

#124975 RE: krielly #124972

Wow Great news! It’s all coming together nicely!

WebSlinger

03/13/19 10:25 AM

#124976 RE: krielly #124972

And AVDX's most current 10Q (for 31 Dec 2018) still shows that they own the rights to OvaDX:

The Company also owns an exclusive license and has distribution rights for OvaDx®, a noninvasive proteomics diagnostic screening test for the early detection of ovarian cancer. Prior to the acquisitions of assets from THI, the Company’s primary activities since inception had been focused on preparing sample specimens in order for OvaDx® to be further tested according to the guidelines outlined by the Food & Drug Administration for the commercial development of diagnostic tests.



The Company’s intangible assets consists of the following:

Intellectual property for the technology transfer agreement and licensing payments for use of various patents for its worldwide exclusive licensed rights to OvaDx, a diagnostic screening test for the early detection of ovarian cancer which the Company is reviewing to assess the commercialization plan. The carrying value of December 31, 2018 and September 30, 2018 was $1,125,161 and $1,166,834, respectively.

Sloan89RH

03/13/19 10:31 AM

#124978 RE: krielly #124972

Do you have a link to the 10Q? It doesn't show up on the AVDX site.